Kidney problems, including kidney failure
In June 2025, the Masidomide (Xinermei) developed by Xinda Biotechnology was officially approved for marketing
KPV also acts through a receptor-independent mechanism: direct suppression of NF-B nuclear translocation, the master transcription factor for inflammatory gene expression
Instead, compounding pharmacies operate under state pharmacy board oversight and must follow USP compounding standards
Neumiller: For SGLT2 inhibitors, it is important to educate people with type 1 diabetes about situations and factors that can increase their risk for experiencing DKA, such as acute illness, engaging in strenuous exercise, excessive alcohol intake, missing insulin doses, dramatic decreases in carbohydrate intake and insulin pump failure